|Other Names||FXYD domain-containing ion transport regulator 5, Dysadherin, FXYD5, DYSAD, IWU1|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Involved in down-regulation of E-cadherin which results in reduced cell adhesion. Promotes metastasis.|
|Cellular Location||Membrane; Single-pass type I membrane protein|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene encodes a member of a family of small membraneproteins that share a 35-amino acid signature sequence domain,beginning with the sequence PFXYD and containing 7 invariant and 6highly conserved amino acids. The approved human gene nomenclaturefor the family is FXYD-domain containing ion transport regulator.Mouse FXYD5 has been termed RIC (Related to Ion Channel). FXYD2,also known as the gamma subunit of the Na,K-ATPase, regulates theproperties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma),FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown toinduce channel activity in experimental expression systems.Transmembrane topology has been established for two family members(FXYD1 and FXYD2), with the N-terminus extracellular and theC-terminus on the cytoplasmic side of the membrane. This geneproduct, FXYD5, is a glycoprotein that functions in theup-regulation of chemokine production, and it is involved in thereduction of cell adhesion via its ability to down-regulateE-cadherin. It also promotes metastasis, and has been linked to avariety of cancers. Alternative splicing results in multipletranscript variants. [RefSeq curation by Kathleen J. Sweadner,Ph.D., email@example.com.].
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Ono, K., et al. Anticancer Res. 30(9):3273-3278(2010)Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009)Liang, J.F., et al. Pathol. Res. Pract. 205(7):445-450(2009)Batistatou, A., et al. Endocr. Pathol. 19(3):197-202(2008)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.